Quality of Life After Ministernotomy Versus Full Sternotomy Aortic Valve Replacement
- PMID: 32853740
- DOI: 10.1053/j.semtcvs.2020.07.013
Quality of Life After Ministernotomy Versus Full Sternotomy Aortic Valve Replacement
Abstract
Quality of life and patient satisfaction after ministernotomy have never been compared to conventional full sternotomy in randomized trials. The QUALITY-AVR trial is a single-blind, single-center, independent, randomized clinical trial comparing ministernotomy to full sternotomy in patients with isolated severe aortic stenosis scheduled for elective aortic valve replacement. One hundred patients were randomized in a 1:1 computational fashion. The primary endpoint was a difference between intervention groups of ≥0.10 points in change from baseline quality of life Questionnaire EuroQOL-index, measured at 1, 6, or 12 months. Secondary endpoints were differences in change from other baseline EuroQOL-index utilities, cardiac surgery-specific satisfaction questionnaire (SATISCORE), a combined safety endpoint of 4 major adverse complications at 1 month (all-cause mortality, acute myocardial infarction, neurologic events, and acute renal failure), bleeding through drains within the first 24 hours, intubation time, and other minor endpoints. Clinical follow-up was scheduled at baseline, 1, 6, and 12 months after randomization. Change from baseline mean difference EQ-5D-index was +0.20 points (95% confidence interval 0.10-0.30, P < 0.001) and median difference +0.14 (95% confidence interval 0.06-0.22, P < 0.001), favoring the ministernotomy group at 1 month. Patient satisfaction was also better at 1 month (Satiscore 83 ± 9 vs 77 ± 13 points; P = 0.010). The ministernotomy group had significantly less bleeding in the first 24 hours (299 ± 140 vs 509 ± 251 mL, P = 0.001). Ministernotomy provides a faster recovery with improved quality of life and satisfaction at 1 month compared to full sternotomy.
Keywords: Aortic valve replacement; Ministernotomy; Quality of life.
Copyright © 2020 Elsevier Inc. All rights reserved.
Comment in
-
Commentary: Randomized Trials Must Provide New and Important Information.Semin Thorac Cardiovasc Surg. 2021 Summer;33(2):335-336. doi: 10.1053/j.semtcvs.2020.08.003. Epub 2020 Aug 25. Semin Thorac Cardiovasc Surg. 2021. PMID: 32853739 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
